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Summary
Apoptosis occurs concurrently with differentiation of muscle progenitor cells (MPCs) before they fuse to form myotubes. Dysregulated
apoptosis in MPCs contributes to the low regeneration capability in aged muscle and decreases the survival rate of donor cells in stem cellbased therapies for muscular dystrophies. This study investigated the role of the M-cadherin/PI3K/Akt/GSK-3b signaling pathway in
regulating apoptosis during differentiation of MPCs. Disruption of M-cadherin-dependent cell–cell adhesion by M-cadherin RNA
interference in confluent C2C12 myoblasts sensitized the cells to mitochondria-associated intrinsic apoptosis induced by cell confluence or
serum starvation. Further investigation of this pathway revealed that M-cadherin-mediated signaling suppressed GSK-3b activation by
enhancing the PI3K/AKT-dependent inhibitory phosphorylation of Ser9 in GSK-3b. Overexpression of wild-type GSK-3b in confluent
C2C12 myoblasts exacerbated the apoptosis, whereas chemical inhibition of GSK-3b using TDZD-8, or forced expression of constitutively
active Akt (myrAkt), or a kinase-deficient GSK-3b mutant [GSK-3b(K85R)], attenuated apoptosis and rescued the impaired myogenic
differentiation that is caused by M-cadherin RNA interference. These data suggest that M-cadherin-mediated signaling prevents
acceleration of mitochondria-associated intrinsic apoptosis in MPCs by suppressing GSK-3b activation during myogenic differentiation.
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Introduction
Muscle progenitor cells (MPCs) or satellite cells remain quiescent
both metabolically and mitotically in adult muscles under normal
basal physiological conditions. Once activated by stimuli such as
muscle injury or exercise, they enter the cell cycle, proliferate,
differentiate and fuse into myotubes for muscle regeneration (Seale
and Rudnicki, 2000; Zammit et al., 2006). The differentiation of
MPCs is critical for myotube formation, but it also occurs
concurrently with apoptosis (Dee et al., 2002; Walsh, 1997).
Apoptosis is a systematic process of programmed cell death that is
important for normal tissue morphogenesis and development by
maintaining the tissue homeostasis. The dysregulation of apoptosis
contributes to a variety of pathologies, including cancer,
autoimmune diseases, cardiovascular disease and degenerative
neurological diseases (Baehrecke, 2002; Quadrilatero and
Bloemberg, 2010; Quadrilatero and Rush, 2008). In skeletal
muscle, apoptosis has been linked to conditions of muscle
wasting caused by disuse, denervation and aging (Alway and Siu,
2008; Siu et al., 2005a; Siu et al., 2005c). In addition, inappropriate
apoptosis of muscle progenitor cells might contribute to the low
regeneration capability of dystrophic muscles and the poor
outcomes of stem-cell-based therapeutic strategies (Gussoni et al.,
1997; Partridge et al., 1998; Tews and Goebel, 1997; Tidball et al.,
1995). Decreased muscle progenitor cell number (Day et al., 2010),
function (Corbu et al., 2010; Leiter and Anderson, 2010) and
altered responses to their niche (Brack and Rando, 2007; Conboy

et al., 2005) contribute to the impaired regenerative capability in
aging skeletal muscle. In addition, muscle progenitor cells that are
isolated from aged muscle are susceptible to apoptosis, and their
number declines because more of them are depleted by apoptosis in
aged muscle (Collins et al., 2007; Jejurikar et al., 2006; Jejurikar
and Kuzon, 2003).
M-cadherin is a member of the classical cadherin family of
transmembrane glycoproteins mediating calcium-dependent
homophilic cell–cell adhesion. M-cadherin is specifically
expressed in skeletal muscle and certain neural tissues. In
mature skeletal muscle, M-cadherin is only detectable on satellite
cells and the underlying sarcolemma of myofibers (Irintchev
et al., 1994; Kaupmann et al., 1992). The number of M-cadherinpositive satellite cells decreases in aged muscle (Sajko et al.,
2004). Although a mouse knockout model indicated that Mcadherin might play a dispensable role in myogenesis and muscle
regeneration in vivo (Hollnagel et al., 2002), data from in vitro
studies showed that by interacting with Rac1 and other members
of Rho subfamily, M-cadherin is critical in mediating myoblast
alignment and fusion into myotubes (Charrasse et al., 2006;
Charrasse et al., 2007; Wrobel et al., 2007). However, its role in
regulating the survival and death of muscle progenitor cells or
myoblasts has never been addressed.
In the present study, we investigated the role of M-cadherindependent cell–cell adhesion on the survival of mouse C2C12
myoblasts as well as primary muscle progenitor cells during
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myogenic differentiation. We were particularly interested in the
potential for M-cadherin to protect against the mitochondriaassociated intrinsic apoptosis that is induced by cell confluence
or serum starvation. By disrupting M-cadherin-dependent

Fig. 1. See next page for legend.

cell–cell adhesion by knocking down M-cadherin expression
using RNA interference, we demonstrated that M-cadherinmediated signaling is important for maintaining mitochondrial
integrity. This occurred by suppressing GSK-3b activation in a

M-cadherin prevents myoblast apoptosis
PI3K/Akt-dependent manner, and reducing apoptotic signaling
through the mitochondrial pathway, thus promoting the survival
of myoblasts during myogenic differentiation. Moreover,
apoptosis and impaired myogenic differentiation that is caused
by reducing M-cadherin protein abundance could be rescued
by the inhibition of GSK-3b activation. Together, these results
suggest an indispensable role of M-cadherin-mediated signaling
in maintaining the balance between apoptosis and differentiation
of muscle progenitor cells during myogenesis and potentially
during activation of muscle stem cells such as that occurring
during muscle regeneration.
Results

Journal of Cell Science

M-cadherin RNA interference exacerbates mitochondriaassociated apoptosis in confluent C2C12 myoblasts

To evaluate the apoptotic propensity to high and low cell
densities, C2C12 myoblasts were seeded in six-well plates
at either 2.06103/cm2 to obtain a low density (,20–30%
confluent) or 2.16104/cm2 to reach a high cell density (,100%
confluent) within 48 hours. The phase-contrast images in the top
panel of Fig. 1A show typical morphology of C2C12 myoblasts
at low or high cell densities. The protein abundance of cleaved
caspase-3 and Poly (ADP-ribose) polymerase (PARP) was
markedly increased in fully confluent cells when compared
with cells that were plated at a low density (Fig. 1, middle panel).
The cleavage of PARP by caspases leads to nuclear DNA
fragmentation. Furthermore, a cell-death ELISA assay showed an
elevation of cytosolic nucleosomes at full cell confluence
(Fig. 1A, bottom panel). This provided additional evidence for
an increase in apoptotic DNA fragmentation in confluent cells
Fig. 1. Effect of M-cadherin RNAi on apoptosis in confluent C2C12
myoblasts. (A) Representative phase-contrast images of C2C12 myoblasts
obtained 48 hours after seeding at low density (2.06103/cm2) or high density
(2.16104/cm2) (top). Scale bar: 200 mm. Immunoblots of cleaved caspase-3
and PARP obtained 48 hours after plating (middle). Cytosolic nucleosomes of
low- or high-density cells were measured as an indication of apoptotic DNA
fragmentation (bottom). Each data point represents the mean ¡ s.e.m. of
three independent experiments. *P,0.05 vs the low-density group.
(B) Expression pattern and protein abundance of M-cadherin at low and high
cell densities. Representative confocal images of M-cadherin (red) and DAPI
(blue) staining in C2C12 myoblasts at low or high cell density as described in
A (top). Scale bar: 10 mm. Immunoblotting analysis of protein abundance of
M-cadherin. b-tubulin was probed as a loading control (bottom). (C–H) 80%
confluent C2C12 myoblasts were transfected with M-cadherin-targeted
siRNA (M-) or non-targeted scramble siRNA (SiCON) as a control. Nontransfected cells with identical culture conditions were used as a normal
control (NC) cells. The cells were harvested 48 hours after transfection. Each
data point is the mean ¡ s.e.m. of three independent experiments. *P,0.05
vs the control groups. (C) Phase-contrast images of transfected cells. Scale
bar: 100 mm. (D) Immunoblot analysis of transfected cells. (E) The apoptotic
DNA fragmentation of transfected cells is shown as mean ¡ s.e.m. of three
independent experiments. *P,0.05 vs both NC and SiCON control groups.
(F) Proteins associated with apoptotic signaling (and the relevant control
proteins) measured in transfected and control cells (left). The integrity and
purity of protein subcellular fractions was verified by immunoblotting with
appropriate control antibodies (right). (G) Digital images from control or
transfected C2C12 cells stained with NAO (top). Scale bar: 20 mm. The
median fluorescence intensity of NAO per cell was determined (bottom). The
data are mean ¡ s.e.m. of three experiments. (H) Mitochondria were isolated
from control and transfected cells and stained with JC-1. The data represent
FACS analyses of the ratio of orange (intact mitochondria) to green
(compromised Dym) mitochondria.
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compared with non-confluent cells. We next explored the
expression pattern and level of M-cadherin at different cell
densities. M-cadherin was located diffusely throughout the cells
that were plated at a low density (Fig. 1B, top left panel). By
contrast, M-cadherin relocated to cell–cell contacts at the
periphery of the cells when they were confluent (Fig. 1B, top
right panel). The protein abundance of M-cadherin increased in
confluent C2C12 myoblasts compared with the non-confluent
cells (Fig. 1B, bottom panel). To investigate the role of Mcadherin in regulating myoblast survival and apoptosis, we
inhibited M-cadherin expression in confluent C2C12 myoblasts
by transient transfection with M-cadherin-targeted small
interfering RNA. Knockdown of M-cadherin expression in
confluent C2C12 myoblasts caused a disruption in the cell–cell
contacts and this increased the separation between the cells
(Fig. 1C). Cells in the control group adhered tightly to each other
as the cells became confluent (Fig. 1C). The knockdown of Mcadherin was verified by immunoblotting (Fig. 1D). The protein
abundance of N-cadherin in C2C12 cells was not affected by Mcadherin RNAi treatment (Fig. 1D). However, M-cadherin RNAi
exacerbated cell-confluence-induced apoptosis in C2C12 cells
as determined by the increased protein abundance of cleaved
caspase-3 and cleaved PARP (Fig. 1D). An increase in DNA
fragmentation as measured by a cell death ELISA assay (Fig. 1E)
confirmed that M-cadherin RNAi increased the level of cellconfluence-induced apoptosis.
Apoptosis is initiated in muscle by three pathways. These
include the extrinsic death-receptor-mediated pathway, the
intrinsic mitochondrial-dysfunction-associated pathway and the
intrinsic ER-dysfunction-associated pathway (Adams, 2003;
Alway et al., 2011; Alway and Siu, 2008). To determine which
apoptotic pathway is involved in cell death caused by M-cadherin
RNAi, we examined the activation status of caspase-9 and
caspase-8, which are representative initiation caspases for the
intrinsic or the extrinsic apoptotic pathway, respectively. The
protein abundance of cleaved caspase-9, but not caspase-8, was
markedly increased in response to M-cadherin RNAi (Fig. 1F). In
addition, the protein abundance of cytosolic cytochrome c and
nuclear apoptosis inducing factor (AIF) were also increased upon
M-cadherin RNAi. This suggests that the apoptosis induced by
M-cadherin RNAi is mediated by the intrinsic mitochondriaassociated pathway. To further investigate the impact of Mcadherin RNAi on mitochondria as a mediator of apoptosis, we
examined the cardiolipin content of the inner mitochondrial
membrane of live cells using Nonyl Acridine Orange (NAO)
staining. NAO is a metachromatic dye that binds specifically to
the mitochondrial cardiolipin and its fluorescence intensity is an
indicator of mitochondrial integrity (Jahnke et al., 2009; Ott et al.,
2007). The median fluorescence intensity of NAO staining in
cells treated with siRNA to knock down M-cadherin was
significantly lower than that in control cells (Fig. 1G). This
indicates that the integrity of mitochondria in C2C12 cells was
disrupted after M-cadherin RNAi. Furthermore, the mitochondria
membrane potential (Dymt) was also disrupted by reducing Mcadherin in confluent cells, as shown by a decrease in the orange
and the increase in the green signals from treated mitochondria
compared with control mitochondria after incubation with the
fluorescent probe JC-1 (Fig. 1H). JC-1 is a mitochondriapermeable lipophilic cation that changes its color from orange
to green as the Dymt decreases. A reduced Dymt results in shifts
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of the emitted light from 590 nm (orange) to 530 nm (green)
(Williamson et al., 2010).

Journal of Cell Science

M-cadherin RNAi sensitizes C2C12 myoblasts to
serum-starvation-induced apoptosis

To further explore the role of M-cadherin in regulating
mitochondrial integrity and cell survival or apoptosis during
myogenic differentiation, M-cadherin RNAi or control C2C12
myoblasts were cultured in serum-free medium. Mitochondria
were isolated and Dymt was assessed by JC-1 staining after 0, 6,
12, 24 or 48 hours of serum starvation. There was a transient
decrease in the ratio of JC-1 orange to green staining of isolated
mitochondria from all groups of cells in response to serum
starvation, but the M-cadherin RNAi group had the lowest Dymt
at all time points compared with the control cells (Fig. 2A).
These results show that knocking down M-cadherin by RNAi
reduced Dymt during serum starvation. The level of apoptotic
DNA fragmentation was significantly increased in M-cadherin
RNAi-treated cells that were still attached to the plates at all time
points of serum starvation compared with the control groups
(Fig. 2B). Furthermore, quantification of apoptotic cells from
both attached and floating cell populations by TUNEL staining,
demonstrated that there was a significant increase in the number
of cells undergoing apoptosis during serum starvation in
M-cadherin RNAi cells compared with the control groups
(Fig. 2C). In addition, there were fewer cells that remained
attached to the plates in the M-cadherin RNAi group compared
with control groups when serum starvation progressed to longer
time periods (supplementary material Fig. S1). Serum starvation
caused an acute activation of caspase-9 in C2C12 myoblasts,
which is indicative of activation of the mitochondrial-associated
apoptotic pathway. The protein abundance of cleaved caspase-9
was significantly higher in M-cadherin RNAi cells at all time
points of serum starvation compared with control untreated cells
(supplementary material Fig. S2). This suggests that knockdown
of M-cadherin expression sensitizes C2C12 myoblasts to serumstarvation-induced apoptosis.
M-cadherin-mediated signaling enhances PI3K/Aktdependent inhibitory phosphorylation of Ser9 of GSK-3b

Akt is a key mediator of survival signaling pathways, and it is
associated with cadherin signaling in various cells (De et al., 2009;
Koutsouki et al., 2005). Because GSK-3b, another key regulator of
cell fate and a phosphorylation target of Akt, is associated with
muscle wasting, we also examined the change in GSK-3b
phosphorylation in response to M-cadherin RNAi treatment in
confluent cells. As a functional read-out for GSK-3b activation,
the protein abundance of two targets for GSK-3b, cyclin D1 (Diehl
et al., 1998) and survivin (Kaga et al., 2006) were measured. Mcadherin RNAi significantly reduced the activation of Akt in
confluent C2C12 cells as determined by the expression of
phosphorylated Akt Ser473 (Fig. 3A). Consequently, the
inhibitory phosphorylation of GSK-3b Ser9 was decreased in
M-cadherin RNAi cells. Quantification of the immunoblot
signals from four independent experiments showed a statistically
significant and a reproducible (bottom panel of Fig. 3A;
supplementary material Fig. S4A,B) reduction in phosphorylated
Akt Ser473, GSK-3b phosphorylation, survivin and cyclin D1 in
C2C12 cells after M-cadherin RNAi. Conversely, the activation of
M-cadherin-mediated signaling using a recombinant M-cadherin–
Fc chimera induced a significant increase in phosphorylation of

Fig. 2. Effect of M-cadherin RNAi on serum-starvation-induced
apoptosis. M-cadherin RNAi (M-), non-targeted scrambled siRNAtransfected (SiCON) or normal control (NC) C2C12 myoblasts were serum
starved from zero to 48 hours before being harvested. *P,0.05 vs both
SiCON and NC control groups. The data are shown as the mean ¡ s.e.m. of
three independent experiments. (A) Mitochondria were isolated from attached
cells after serum starvation for 0 hours (SS-0h), 6 hours (SS-6h), 12 hours
(SS-12h), 24 hours (SS-24h) or 48 hours (SS-48h). The mitochondria Dym
(orange to green ratio) was evaluated by FACS analysis of JC-1 staining.
(B) DNA fragmentation in attached cells was measured by a cell death ELISA
at the same time points as described in A. (C) The percentage of cells
undergoing apoptosis in both attached and floating cells was defined as: (total
TUNEL-positive attached cells + total TUNEL-positive floating cells)/(total
attached cells + total floating cells).

Akt and GSK-3b at the corresponding residues (Fig. 3B;
supplementary material Fig. S5A,B). The protein abundance of
survivin and cyclin D1 decreased in response to suppression of Mcadherin by RNAi (Fig. 3A; supplementary material Fig. S4C,D).
In addition, the protein abundance of survivin and cyclin D1
increased in response to rMFc treatment (Fig. 3B; supplementary
material Fig. S5C,D). Immunoprecipitation data show that the
binding between the p85a subunit of PI3K and M-cadherin was
increased in response to treatment with recombinant M-cadherin–
Fc chimera (Fig. 3C). The abundance of PI3K-p85a protein in the
membrane fraction was markedly increased in M-cadherin–Fc-
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Fig. 3. M-cadherin-mediated signaling effect on the PI3K/Akt/GSK-3b pathway. (A) Representative immunoblots of M-cadherin-RNAi (M-) treated, nontargeted scrambled siRNA-transfected (SiCON) treated or normal control (NC) C2C12 cells (top). Survivin and cyclin D1 were measured as a functional read-out
for GSK-3b activation. GAPDH was used as a loading control. Densitometric analyses of Akt, GSK-3b, survivin and cyclin D1 normalized to their loading
controls (bottom). (B) C2C12 myoblasts were grown in normal control (NC), vehicle control (Vehicle) or recombinant M-cadherin–Fc-coated (M-cad–Fc) dishes
for 48 hours (top). The cells were lysed and subjected to immunoblotting analysis of the same proteins as measured in Fig. 3A. Densitometric analyses of
immunoblot band intensities of phosphorylated and total Akt and GSK-3b, as well as survivin and cyclin D1 in response to recombinant M-cadherin–Fc treatment
(bottom). The band intensities of the above proteins were normalized by corresponding control proteins. (C) Immunoprecipitation assays of untreated C2C12
myoblasts (NC) or myoblasts treated with either the vehicle (Veh) or with recombinant M-cadherin–Fc (rMFc) were conducted 48 hours after incubation with
either mouse anti-PI3K-p85a or rabbit anti-M-cadherin antibodies, respectively. Western blots of the protein abundance of M-cadherin or PI3K-p85a were
conducted in the precipitated proteins. (D) Cell membrane fractions were prepared from cells that had been treated as described in C and blotted to detect the
protein abundance of PI3K-p85a. (E) C2C12 myoblasts were treated as described in C. The cells were then treated for a subsequent 12 hours with no vehicle
added (-), wortmannin (WM, 200nM), PD98059 (PD, 50 mM), wormannin plus PD98059 (WM+PD) or DMSO. Untreated normal control cells (NC) did not
receive either the recombinant M-cadherin–Fc or the vehicle treatments. The cells were harvested for immunoblotting analysis. The data are shown as the mean ¡
s.e.m. of three independent experiments. *P,0.05 vs the control groups.
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treated cells compared with the control cells (Fig. 3D). Treatment
with the PI3K inhibitor, wortmannin, but not the MEK-1 inhibitor,
PD9805, during the last 6 hours of M-cadherin–Fc treatment,
completely prevented the increase in phosphorylated Akt Ser473
and phosphorylated GSK-3b Ser9. This shows that the increased
inhibitory phosphorylation of GSK-3b that is induced by Mcadherin-mediated signaling, is PI3K dependent (Fig. 3E).
GSK-3b overexpression exacerbates, whereas
M-cadherin–Fc treatment attenuates apoptosis induced by
cell confluence or serum starvation

Journal of Cell Science

To further characterize the role of GSK-3b in regulating apoptosis,
C2C12 myoblasts that were 80% confluent were transiently
transfected with a wild-type GSK-3b plasmid and allowed to grow
for 48 hours until they reached overconfluence. The transfection
efficiency of the GSK-3b plasmid by FuGENE 6 in C2C12 cells
was estimated to be ,20–30% (supplementary material Fig. S3A).

Immunoblot analysis confirmed that transfection with GSK-3b
increased the protein abundance of GSK-3b and also decreased
the protein level of cyclin D1 (Fig. 4A), a target of GSK-3b
phosphorylation that induces its degradation. Overexpression of
wild-type GSK-3b in confluent C2C12 myoblasts increased the
protein abundance of cleaved caspase-9, caspase-3 and PARP.
This effect was reversed by co-treating the cells with recombinant
M-cadherin–Fc (Fig. 4B,C). In addition, Dymt was decreased in
mitochondria from C2C12 cells upon overexpression of wild-type
GSK-3b, which was rescued by co-treatment with recombinant
M-cadherin–Fc (Fig. 4D). Together, these data indicate that
overexpression of wild-type GSK-3b alone is sufficient to
exacerbate the mitochondria-associated apoptosis induced by cell
confluence, and this effect can be reversed by enhancement of Mcadherin-mediated signaling by treatment with M-cadherin–Fc.
Furthermore, in response to serum starvation, cells transfected with
wild-type GSK-3b plasmid had significantly higher cell death than

Fig. 4. Effect of wild-type GSK-3b overexpression and
recombinant M-cadherin–Fc treatment on apoptosis induced by
cell confluence or serum starvation. (A) A wild-type GSK-3b
plasmid (GSK-3bWT) or an empty vector (EV) were transiently
transfected into C2C12 myoblasts that were 80% confluent.
48 hours after transfection, cells were harvested in RIPA buffer and
processed for immunoblotting for GSK-3b and cyclin D1 protein
abundance. The experiment was repeated three times under each
experimental condition. (B) Wild-type GSK-3b plasmids (GSK3bWT) or empty vectors (EV) were transiently transfected into
C2C12 myoblasts growing in recombinant M-cadherin–Fc-coated
(M-cad-Fc) or vehicle-coated (Vehicle) dishes. 48 hours later, the
cells were harvested in RIPA buffer and immunoblotted against proapoptotic proteins. GAPDH was probed as a loading control.
(C) Densitometric analyses of immunoblot bands described in B.
The data were normalized to GAPDH and expressed as the mean ¡
s.e.m. of three independent experiments. *P,0.05 vs EV/Vehicle or
EV/M-cad-Fc. {P,0.05 vs GSK-3bWT/Vehicle. (D) Mitochondria
were isolated from C2C12 myoblasts that had undergone the same
treatments as described in B. The mitochondria were stained with
JC-1. A FACSCalibur system was used to measure the change in
mitochondrial membrane potential (Dym). The data are expressed as
the ratio of orange to green JC-1 staining. The data are reported as
the mean ¡ s.e.m. of three independent experiments. *P,0.05 vs
EV/Vehicle or EV/M-cad-Fc. {P,0.05 vs GSK-3bWT/Vehicle.
(E) C2C12 myoblasts transfected with the wild-type-GSK-3b
plasmid (GSK3bWT) or the empty vector (EV) and the nontransfected normal control (NC) cells were serum-starved for
0 hours (SS-0h), 6 hours (SS-6h), 12 hours (SS-12h), 24 hours (SS24h) or 48 hours (SS-48h). At the end of each time point, the
attached cells were harvested and DNA fragmentation was measured
by a cell death ELISA assay. The data represent the mean ¡ s.e.m.
from three independent experiments. *P,0.05, vs NC or EV.
(F) The wild-type GSK-3b plasmid (GSK3bWT) or the empty
vector (EV) was transiently transfected into C2C12 myoblasts
growing in recombinant M-cadherin–Fc-coated (M-cad-Fc) or
vehicle-coated (Vehicle) dishes. 48 hours later, the cells were
treated with serum starvation for another 48 hours before being
harvested. A cell death ELISA assay was used to measure the DNA
fragmentation in the harvested cells. The data represent the mean ¡
s.e.m. from three independent experiments. *P,0.05 vs EV/Vehicle
or EV/M-cad-Fc. {P,0.05 vs GSK-3bWT/Vehicle.

M-cadherin prevents myoblast apoptosis
the control cells at all time points, suggesting that overexpression
of wild-type GSK-3b sensitized the cells to serum-starvationinduced apoptosis (Fig. 4E). By contrast, co-treatment of C2C12
cells with M-cadherin–Fc and GSK-3b overexpression after
48 hours of serum starvation significantly attenuated cell death,
compared with GSK-3b overexpression alone (Fig. 4F).
GSK-3b inhibition attenuates apoptosis exacerbated by
M-cadherin RNAi

Journal of Cell Science

The effect of GSK-3b inhibition on regulating apoptosis was
examined using a myristoylated Akt mutant (myrAkt), which
functions as a constitutively active form of Akt (Ahmed et al.,
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1997), to inhibit GSK-3b activity and a V5-tagged kinasedeficient mutant GSK-3b(K85R), which functions as a dominantnegative GSK-3b (Ma et al., 2008). The transfection efficiency of
these plasmids using DharmaFECT Duo in C2C12 myoblasts was
estimated to be 25-35% as determined from transfection studies
using the pEGFP-C3 vector and DharmaFECT DUO as the
transfection agent (supplementary material Fig. S3B).
To evaluate the effects of GSK-3b inhibition on apoptotic
signaling, C2C12 cells that were 80% confluent were transfected
with M-cadherin-targeted siRNA, plus either the myrAkt or the
GSK-3b(K85R) plasmid, or an empty vector. The cells were
allowed to grow for 48 hours at which time they had reached
overconfluency. As expected, there was a significant increase in
both phosphorylated Akt and total Akt abundance in the cells
transfected with the myrAkt plasmid (Fig. 5A, right panel). In
addition, there was an increase in total GSK-3b and cyclin D1
protein abundance in the cells that were transfected with GSK3b(K85R) plasmids (Fig. 5A, left panel). Forced expression of
myrAkt or GSK-3b(K85R) plasmids significantly attenuated
apoptosis as seen by lower levels of cleaved caspase-9, cleaved
caspase-3 and cleaved PARP (Fig. 5B,C) after M-cadherin RNAi
or overconfluency. Furthermore, the DNA fragmentation that
resulted from 48 hours of serum starvation or M-cadherintargeted siRNA, was significantly reduced when the C2C12 cells
were co-transfected with either myrAkt or GSK-3b(K85R)
plasmids (Fig. 6A). To further confirm the impact of GSK-3b
inhibition on the regulatory effect of M-cadherin on apoptosis,
we transfected the cells with M-cadherin siRNA for 36 hours
followed by treatment with a specific GSK-3 inhibitor TDZD-8
(20 mM) for 12 hours. TDZD-8 treatment abrogated apoptosis
and reversed the loss of Dymt that was caused by M-cadherin
RNAi following a period of 48 hours of serum starvation
(Fig. 6B,C).
GSK-3b inhibition partially restores the myogenic
differentiation impaired by M-cadherin RNAi

Finally, we sought to investigate the impact of M-cadherin
RNAi and GSK-3b inhibition on the outcome of myogenic
differentiation. M-cadherin RNAi C2C12 myoblasts treated with

Fig. 5. Effect of GSK-3b inhibition on cell-confluence-induced apoptosis.
(A) C2C12 myoblasts were grown to 80% confluency then transfected with an
empty vector (EV) or GSK-3bK85R, which contained a V5 tag (left panel), or
constitutively active Akt (myrAkt) (right panel) for 48 hours. Non-transfected
cells normal control cells (NC) were cultured under identical conditions. The
protein abundances of V5 tag, GSK-3b, and cyclin D1 were examined in cells
transfected with GSK-3bK85R plasmid (left panel) and those of Ser437phosphorylated and total Akt were examined in myrAkt plasmid-transfected
cells (right panel) by immunoblotting. (B) C2C12 myoblasts were grown to
80% confluency then co-transfected with the M-cadherin-targeted siRNA
(M-) plus myrAkt (M-/myrAkt) or the GSK-3bK85R plasmid (M-/GSK3bK85R) or an empty vector (M-/EV). Similar co-transfections were
completed with the non-targeted scramble siRNA (SiCON) with myrAkt
(SiCON/myrAkt), GSK-3bK85R (SiCON/GSK-3bK85R) or the empty vector
(SiCON/EV). 48 hours after transfection, the cells were harvested and
processed for immunoblotting of cleaved caspase-9, cleaved caspase-3 and
cleaved PARP. GAPDH was used as a loading control. Each experiment was
repeated three times. (C) Densitometric analyses of immunoblots were
obtained from C2C12 cells with identical treatments as described in Fig. 5B.
The data represent the mean ¡ s.e.m. of three independent experiments.
*P,0.05 vs SiCON/EV. {P,0.05 vs M-/EV.
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This was determined by the myoblast fusion index, which
represented the percentage of myoblasts that matured into
myotubes (Fig. 7A,B). Calculation of the apoptotic index from
TUNEL labeling showed that TDZD-8 treatment significantly
attenuated the number of apoptotic nuclei that was caused by
M-cadherin RNAi over 48 hours of myogenic differentiation
(Fig. 7A,C).
These findings were further verified in mouse primary
myoblasts. Syndecan-4-positive primary myoblasts were
isolated by fluorescence-activated cell sorting (FACS) as
representative muscle progenitor cells (Brack and Rando, 2007;
Cornelison et al., 2001). About 20% of the adult muscle stem
cells were syndecan-4 positive. Knockdown of M-cadherin by
RNAi significantly impaired myotube formation from syndecan4-positive primary myoblasts, which was partially rescued
by TDZD-8 treatment as shown by MyHC staining and a
greater fusion index (Fig. 8B,C) in the TDZD-8-treated cells.
Furthermore, M-cadherin RNAi exacerbated apoptosis in
syndecan-4-positive primary myoblasts after 48 hours of
myogenic differentiation. Apoptosis could be abrogated by
TDZD-8 treatment, as shown by reduced TUNEL staining
(Fig. 8B) and a lower apoptotic index (Fig. 8D) after TDZD-8
treatment.

Fig. 6. Effect of GSK-3b inhibition on serum-starvation-induced
apoptosis. (A) C2C12 cells were co-transfected with M-cadherin-targeted
siRNA and one of the plasmids (myrAkt, GSK-3bK85R or empty vector) for
48 hours, then serum-starved for 48 hours. DNA fragmentation was measured
by ELISA. {P,0.05 vs M-/EV. (B) C2C12 cells were transiently transfected
with M-cadherin RNAi (M-), or a non-targeted scrambled siRNA (SiCON).
These were compared with normal non-transfected C2C12 cells (NC). The cells
were treated with 20 mM TDZD-8 or DMSO for the last 12 hours of siRNA
transfection. 48 hours after transfection, the treated and control cells were
serum starved for 48 hours. The cells were harvested and DNA fragmentation
was assessed by cell death ELISA. Each experiment was repeated three times.
{
P,0.05 vs SiCON/TDZD8 and M-/DMSO. (C) Mitochondria were isolated
from each experimental group and stained with JC-1. The ratio of JC-1 orange
to green staining was analyzed using a FACSCalibur system to measure the
mitochondrial membrane potential. {P,0.05 vs M-/DMSO. All experiments
were repeated three times. *P,0.05 vs NC or SiCON.

or without TDZD-8 were cultured in differentiation medium for
48 hours to induce myogenic differentiation. Immunofluorescent
staining of myosin heavy chain (MyHC) was used as a terminal
myogenic marker. A TUNEL assay was performed to determine
the level of in situ apoptotic DNA fragmentation. Knockdown
of M-cadherin by RNAi significantly impaired myogenic
differentiation, because many cells died and detached from the
plates. By contrast, TDZD-8 treatment partially restored the
myogenic differentiation that was blocked by M-cadherin RNAi.

Discussion
This is the first report to show that M-cadherin-mediated
signaling protects myoblasts against apoptosis during myogenic
differentiation. In vitro culture of myoblasts at high cell
density has been shown to yield not only a better myogenic
differentiation outcome, but also an increased incidence of
apoptosis, compared with culturing the cells at a low density (Dee
et al., 2002). This observation is consistent with the suggestion
that apoptosis and differentiation are tightly regulated in a
coordinated pattern in myoblasts (Walsh, 1997). In the current
study, we show that M-cadherin protein abundance is increased
and M-cadherin engagement at cell–cell contacts is induced
when myoblasts become confluent. Although confluence triggers
apoptosis during differentiation, other cells survive, differentiate
and fuse into myotubes (Allombert-Blaise et al., 2003; Dee et al.,
2002; Fernando and Megeney, 2007; Lippens et al., 2005; Walsh,
1997).
In this study, we showed that the disruption of M-cadherin
signaling by M-cadherin RNAi, sensitized C2C12 myoblasts to
apoptosis that was induced by either cell confluence or serum
starvation. Apoptosis in C2C12 cells is accompanied by decreased
Dymt, increased mitochondrial release of cytochrome c and AIF,
and consequently, increased cleavage of caspase-9 but not caspase8. Together, these data indicate that apoptosis induced by Mcadherin RNAi is mediated by the intrinsic mitochondriaassociated pathway, and that M-cadherin-mediated signaling
plays an important role in maintaining the mitochondrial
integrity of differentiating myoblasts and suppressing apoptosis
during myogenic differentiation. Our findings are consistent with
data showing that Dymt is compromised in myoblasts undergoing
apoptosis, but not those that successfully differentiate (van den
Eijnde et al., 2001). Furthermore, proper mitochondria function is
crucial for successful myogenic differentiation (Jahnke et al.,
2009; Rochard et al., 1996; Rochard et al., 2000).
Previous findings have shown that in aged muscle, the number
of M-cadherin-positive satellite cells is decreased (Sajko et al.,
2004), but the apoptotic propensity of satellite cells is increased
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Fig. 7. Effect of M-cadherin RNAi and GSK-3b inhibition on myogenic differentiation of C2C12 myoblasts. C2C12 cells were grown on coverslips,
transfected with M-cadherin-targeted (M-) or non-targeted scrambled siRNA (SiCON) for 36 hours then incubated with or without TDZD-8 for 12 hours. The
cells were then cultured in differentiation medium for 48 hours. (A) Representative confocal images of C2C12 myoblasts after treatment with a combination of Mcadherin RNAi (M-) or non-targeted scrambled siRNA transfection (SiCON) and TDZD-8 or DMSO as a vehicle control. The cells were cultured in differentiation
medium for 48 hours after the co-treatments. MyHC, red; DAPI, blue; TUNEL, green. Scale bar: 100 mm. (B,C) Data from three independent experiments as
mean ¡ s.e.m. *P,0.05 vs SiCON/DMSO; {P,0.05 vs M-/DMSO. The myoblast fusion index was calculated for cells after each treatment described in Fig. 7A,
as the ratio of the number of DAPI-positive nuclei located in the MyHC-positive myotubes (i.e., fused myoblasts) divided by the total number of nuclei in the same
field (B). The apoptotic index was calculated as the percentage of total nuclei that were TUNEL positive (C).

compared with those in young animals (Jejurikar et al., 2006;
Jejurikar and Kuzon, Jr, 2003). This suggests that there is a
negative relationship between the expression levels of Mcadherin and the apoptosis susceptibility of muscle progenitor
cells. In the current study, we showed that M-cadherin has a
protective role against apoptosis during myogenic differentiation
because inhibition of M-cadherin expression by RNAi, sensitized
both C2C12 and syndecan-4-positive primary myoblasts to
apoptosis, which resulted in an increase in pro-apoptotic
markers and in impaired myotube formation compared with
levels in control cells. We speculate that reduced M-cadherin
might be a contributing mechanism that would explain, at least in
part, a increased susceptibility of muscle progenitor cells to
increased apoptotic signaling and elimination of nuclei in aged
muscles (Alway et al., 2011; Alway and Siu, 2008; Jejurikar
et al., 2006; Jejurikar and Kuzon, Jr, 2003).
GSK-3b is a serine-threonine kinase that is constitutively
active in resting cells and plays a key role in regulating glucose
homeostasis (Frame and Cohen, 2001). GSK-3b is also important
in regulating apoptosis. However, it has a paradoxical effect on
apoptosis from different pathways by promoting mitochondrialdysfunction-associated apoptosis signaling, but also inhibiting
death-receptor-mediated apoptosis signaling (Beurel and Jope,

2006). Dysregulation of GSK-3b has been reported to be
involved in several pathologies, including neurodegenerative
diseases, mood disorders, cancer and diabetes (Beurel and Jope,
2006). Studies in skeletal muscles have linked GSK-3b to
muscle-wasting conditions. GSK-3b activity has been shown to
increase in aged (Kinnard et al., 2005) and burn-injured skeletal
muscles (Fang et al., 2007). Inhibition of GSK-3b is required for
IGF-1-induced myogenic differentiation (Vyas et al., 2002).
Furthermore, GSK-3b inhibition reduces protein degradation in
conditions of muscle wasting and might also promote re-growth
of atrophic muscle (Evenson et al., 2005; van der Velden et al.,
2006; van der Velden et al., 2007). Although a conditional
skeletal muscle knockout of GSK-3b has been reported to
manifest a phenotype with an improved insulin tolerance and
glucose metabolism in muscle tissues (Patel et al., 2008),
currently, there are no data that evaluate a direct role of GSK3b in regulating the muscle progenitor cell survival and apoptosis
during myogenic differentiation. In this study, we show for the
first time that overexpression of wild-type GSK-3b is sufficient
to induce apoptosis in confluent C2C12 myoblasts and to
sensitize the cells to serum-starvation-induced apoptosis. This
effect can be attenuated by increasing M-cadherin-mediated
signaling by recombinant M-cadherin–Fc treatment. We also
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Fig. 8. Effect of M-cadherin RNAi and GSK-3b inhibition on apoptosis and myogenic differentiation of primary syndecan-4-positive myoblasts. Primary
myoblasts were isolated from hindlimb muscles of 1-week-old C57BL/6 mice and syndecan-4-positive myoblasts were purified from isolated cells by
fluorescence activated cell sorting (FACS). (A) Approximately 20.2% cells of adult stem cells that were isolated from hindlimb skeletal muscles were syndecan-4
positive (left). The post-sort verification of FACS sorted cells indicated that the purity of syndecan-4-positive cells was 97% (right). (B) Syndecan-4-positive
myoblasts were grown on coverslips and treated as described in Fig. 7. The imaging of the cells was the same as in Fig. 7A. (C,D) Data from three independent
experiments were given as mean ¡ s.e.m. *P,0.05 vs SiCON/DMSO. {P,0.05 vs M-/DMSO. (C) The myoblast fusion index was calculated as described in
Fig. 7B. (D) The apoptotic index was calculated as described in Fig. 7C.

show that the activation of M-cadherin-mediated signaling
recruits PI3K and activates Akt, which in turn phosphorylates
GSK-3b at the Ser9 residue, resulting in its suppression.
Conversely, inhibition of GSK-3b activation attenuates
apoptosis that is induced by knockdown of M-cadherin
expression. This suggests that GSK-3b plays a crucial role in
mediating the protective effect of M-cadherin against apoptosis
during myogenic differentiation. Our findings are consistent with
data from Robakis and colleagues (Baki et al., 2004) who showed
that the expression of presenilin-1 in fibroblasts promotes the
association of PI3K with E- and N-cadherins and activates Akt,
leading to the inhibition of GSK-3b activity. Skeletal muscle is
the largest consumer of glucose, and GSK-3b plays an important
role in regulating glucose metabolism and insulin sensitivity in
muscle (Patel et al., 2008; Pearce et al., 2004). Thus we speculate
that manipulation of M-cadherin-mediated cell–cell adhesion

might have a profound impact on glucose metabolism and insulin
tolerance of muscle tissue through regulating the activation status
of GSK-3b. Interestingly, a type 2 diabetic phenotypic KK/Ta
mouse, has been shown to have an ectopic expression of Mcadherin with three missense mutations in liver (Shiina et al.,
2007). Further statistical analysis revealed a correlation between
M-cadherin expression and the hypertriglyceridemia, glucose
intolerance and hyperinsulinemia in the KK/Ta mouse. This
suggests that disrupted M-cadherin signaling might have a role in
the pathology of type 2 diabetes (Shiina et al., 2007).
GSK-3b might regulate mitochondrial outer membrane
permeabilization by targeting multiple substrates. The Bcl-2
family of proteins represents one target of GSK-3b. GSK-3b
directly phosphorylates the pro-apoptotic Bax protein at Ser163,
leading to its activation (Linseman et al., 2004). GSK-3b
activation also induces the expression of the pro-apoptotic Bim
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protein (Hongisto et al., 2003). However, GSK-3b phosphorylation
of MCL-1, an anti-apoptotic member of Bcl-2 family protein,
facilitates its degradation (Maurer et al., 2006). Another class
of GSK-3b substrates in regulating apoptosis is a group of
transcription factors that include p53, b-catenin and Myc. p53
plays a crucial role in regulating cell cycle arrest, senescence and
apoptosis. GSK-3b can form a complex with nuclear p53 and this
promotes p53-induced apoptosis (Watcharasit et al., 2003). bcatenin is a key mediator for the canonical Wnt signaling pathway,
which has an important role in promoting cell growth and survival.
b-catenin also connects cadherins to the actin cytoskeleton.
Together with adenomatous polyposis coli (APC) and axin,
GSK-3b forms the ‘destruction complex’ that phosphorylates bcatenin and promotes its ubiquitylation and degradation (Ewan
et al., 2010). Cadherins control both the turnover rate and the
subcellular distribution of b-catenin. As a result, b-catenin could
be the nexus for the convergence of cadherin and GSK-3bmediated signaling in skeletal muscle. Additional studies are
required to identify the important upstream mediators and
downstream targets for M-cadherin–Akt–GSK-3b signaling that
are responsible for maintaining mitochondrial integrity and
suppressing apoptosis in myoblasts; however, this is beyond the
scope of the current investigation.
In conclusion, the data in the current study show that Mcadherin plays a critical role in regulating survival versus death
by apoptosis of myoblasts during myogenic differentiation in
vitro. M-cadherin-mediated signaling maintains the inhibitory
tone from PI3K–Akt upon GSK-3b by activating PI3K–Akt. Mcadherin signaling appears to help maintain a balance between
apoptosis and differentiation and prevents the acceleration of
mitochondrial-associated apoptotic signaling in muscle cells.
Materials and Methods
Cell culture

C2C12 myoblasts were purchased from American Type Culture Collection
(Manassas, VA) and maintained in Dulbecco modified Eagle’s medium (DMEM)
(Invitrogen Life Technologies, Bethesda, MD) supplemented with 10% fetal
bovine serum (FBS) and 1% antibiotic and antimycotic mixture solution
(Invitrogen).
Primary myoblasts were isolated from hindlimb muscles of one-week old
C57BL/6 mice (Goodell et al., 2001) and purified by Percoll (Sigma, St Louis,
MO) gradient centrifugation. The syndecan-4-positive myoblasts were identified
by fluorescence-activated cell sorting (FACS) using an antibody against syndecan4 (BD). The Syndecan-4-positive myoblasts were cultured in Ham’s F10
supplemented with 20% FBS at 37 ˚C.
Serum starvation was induced by incubating the cells in serum-free DMEM
supplemented with 1% antibiotic and antimycotics. Myogenic differentiation was
induced by culturing the confluent cells in differentiation medium (DMEM, 2%
horse serum, 1% antibiotic and antimycotic).
Chemical inhibitors

The cells were treated with the PI3K inhibitor wortmannin (200 nM, Alexis
Biochemicals, Plymouth Meeting, PA), the GSK-3 inhibitor TDZD-8 (25 mM,
Sigma) or the MEK1 inhibitor PD98059 (50 mM, Cell Signaling, Danvers, MA).
Inhibition of M-cadherin expression by RNA interference

The myoblasts were seeded at a density of 1.76105 per well in a six-well plate,
24 hours before transfection with SMARTpool small interfering RNA (siRNA)
targeted to M-cadherin mRNA (Life Thermo). The transfection medium included
either DharmaFECT-3 reagent (Life Thermo) (for C2C12 myoblasts) or
Lipofectamine 2000 (Invitrogen) (for primary myoblasts) at a final siRNA
duplex concentration of 100 nM. The efficacy of M-cadherin protein knockdown
by RNAi was confirmed by immunoblotting (supplementary material Fig. S2).
Plasmids and transfection

The full-length mouse wild-type GSK-3b cDNA was generated by RT-PCR.
mRNA was derived from wild C2C12 myoblasts using Trizol reagent (Life
Technologies) and reverse-transcribed into cDNA using Superscript II (Life
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Technologies). The PCR product was cloned into the expression vector pcDNA3.1/
myc-His(-) (Invitrogen). The constitutively active mutant of Akt (myrAkt) and the
V5-tagged kinase-deficient GSK-3b mutant (K85R) carried by vector pcDNA3
were generous gifts from Jia Luo, University of Kentucky, Lexington, KY. The
cells were transfected with the wild-type GSK-3b plasmids using FuGENE 6
(Roche Diagnostics, Indianapolis, IN). The co-transfection of siRNA against Mcadherin with myrAkt or GSK-3b (K85R) plasmids was carried out using
DharmaFECT Duo transfection reagent (Dharmacon, Thermo-Fisher Scientific,
Lafayette CO).
Recombinant M-cadherin–Fc treatment

The recombinant M-cadherin–Fc chimera was purchased from R&D Systems
(Minneapolis, MN). Six-well plates were pre-coated with goat anti-Fc antibody
(0.5 mg/cm2 in PBS with Ca2+; Jackson ImmunoResearch, West Grove, PA)
overnight at 4 ˚C followed by coating with recombinant M-cadherin–Fc chimera at
a final concentration of 2 mg/cm2 in 0.1% BSA in PBS with Ca2+ for 2 hours at
room temperature. The dishes were blocked with 1% BSA in HBSS with Ca2.
Plates coated with only the anti-Fc antibody were used as vehicle controls. The
cells were seeded at 0.56105 cells per well and grown for 48 hours before being
harvested for further assays.
Subcellular fractionation

The membrane fraction of C2C12 myoblasts was prepared using a commercial
reagent (Thermo Fisher). The nuclear protein fraction was prepared according to
methods that have been previously described (Siu and Alway, 2005). The
mitochondrial, mitochondria-free and nuclei-free cytosolic fractions were prepared
using mitochondria and cytosol reagents (BioVision, Mountain View, CA). The
concentration of the protein extracts was quantified in duplicate by Bio-Rad DC
Protein Assay (BioRad, Hercules, CA). The whole-cell lysate was obtained by
disrupting the cells with RIPA buffer supplemented with protease and phosphatase
inhibitor cocktails (Sigma, 1:100 dilution) followed by centrifugation. The
supernatant was collected as the whole-cell lysate.
Immunoblotting

Antibodies specific to phosphorylated Ser473 Akt, total Akt, phosphorylated Ser9
GSK3b, total GSK3b, cytochrome c, cleaved caspase-9 and cleaved caspase-3,
AIF, survivin (1:1000) and cyclin D1 (1:2000 dilution) were purchased from Cell
Signaling Technology (Danvers, MA). The anti-M-cadherin antibody (1:200) was
obtained from Calbiochem (La Jolla, CA). The anti-caspase-8 antibody (1:250)
was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-histone
H2B (1:5000), -b-tubulin (1:500) and anti-GAPDH (1:5000) were obtained from
Abcam (Cambridge, MA). The antibodies against manganese superoxide
dismutase (MnSOD) and copper-zinc superoxide dismutase (Cu-ZnSOD)
(1:1000) were purchased from Millipore (Billerica, MA). The secondary
antibodies for immunoblotting including goat anti-rabbit or goat anti-mouse IgG
conjugated with horseradish peroxidase (HRP) were obtained from Jackson
ImmunoResearch Laboratories (West Grove, PA). The proteins were separated on
a 4–12% gradient polyacrylamide gel (Invitrogen), and transferred to a
nitrocellulose membrane (Bio-Rad). The membranes were probed with primary
antibodies overnight at 4 ˚C, followed by incubation of the appropriate secondary
antibody for 1 hour at room temperature. The resulting signals were developed
using an enhanced chemiluminescence lighting (ECL) western blotting detection
reagent kit (GE Health Care, Piscataway, NJ). Digital records were obtained from
each blot and the protein bands of interest were quantified using 1D analysis
software (Eastman Kodak). The membranes were stripped and reprobed for btubulin, GAPDH or histone H2B as loading controls.
Immunoprecipitation

The cells were washed in ice-cold PBS and lysed in ice-cold buffer (150 mM
NaCl, 50 mM Tris-HCl, pH 7.5, 0.25% SDS, 0.1% Nonidet P-40). Non-soluble
materials were removed by centrifugation at 12,000 g. The lysate was incubated
with anti-PI3K-p85a (Abcam), anti-M-cadherin (Santa Cruz) or IgG (Millipore)
overnight at 4 ˚C. The sample was then incubated with Protein A/G PLUS-agarose
beads (Santa Cruz) and the beads were then collected by centrifugation. The bound
proteins were eluted from the agarose beads in 56 Laemmli sample buffer at 95–
100 ˚C. The samples were clarified by centrifugation and the supernatants were
separated by SDS-PAGE and immunoblotted against M-cadherin or PI3K-p85a.
Cell imaging

Phase-contrast images of live C2C12 and primary myoblast cells were obtained by
a Nikon Eclipse TS100 phase-contrast microscope equipped with 106 0.25 NA
and 206 0.40 NA phase-contrast objectives. The digital images were obtained
with a SPOT RT camera and analyzed with SPOT RT software (Diagnostic
Instruments, Sterling Heights, MI). Immunocytochemical assays were conducted
on fixed cells after they had been grown on coverslips. After fixation in 4%
paraformaldehyde, the cells were incubated at 4 ˚C with antibodies against anti-Mcadherin (1:20, Calbiochem) or anti-myosin heavy chain (MyHC) (1:500,
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Developmental Studies Hybridoma Bank, Iowa City, IA). The cells were incubated
with the Alexa Fluor 546 IgG (H+L) (Invitrogen) and counterstained with 4,6diamidino-2-phenylindole (DAPI). The cells were imaged with a Zeiss
LSM510 confocal laser-scanning microscope using AIM software (Carl Zeiss
MicroImaging).
Myoblast fusion index

The myoblast fusion index was calculated as the ratio of the number of DAPIpositive nuclei located in the MyHC-positive myotubes (i.e. fused myoblasts)
divided by the total number of nuclei in the same field. This fusion index was used
as a read-out of myogenic differentiation. The fusion index was obtained from 10
non-overlapping areas of each coverslip.
Apoptosis assays
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DNA fragmentation
DNA fragmentation was used to assess the level of apoptosis in muscle cells using
an ELISA (Roche) with measurements for DNA fragmentation that were made at
an absorbance of 405 nm (Siu et al., 2009; Siu and Alway, 2005). The data were
normalized to the protein concentration of the sample.
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
A TUNEL assay (Roche) was used to identify the extent of apoptotic nuclei in
adherent myoblasts as reported previously (Siu et al., 2005b). The nuclei of all
cells were counter-stained with DAPI. The number of TUNEL- and DAPI-positive
nuclei was counted in ten images from non-overlapping areas of each group of
cells. The data were presented as the apoptosis index, which was determined by the
ratio of TUNEL-positive nuclei to the total number of DAPI-positive nuclei.
Because treatment with serum starvation and M-cadherin-siRNA resulted in
apoptosis and cell death, some cells detached from the plates. To identify the full
extent of apoptosis, and determine whether M-cadherin RNAi increased
the sensitivity of C2C12 myoblasts to serum-starvation-induced apoptosis, we
assessed apoptosis by a TUNEL assay in both adherent and floating cells in each
well using published methods (Dee et al., 2002). The total percentage of apoptotic
cells for each well was calculated as: (total number of TUNEL-positive attached
cells + the total number of TUNEL-positive floating cells) /(total attached cells +
total floating cells).
Cardiolipin content and mitochondrial membrane potential measurement

Nonyl acridine orange (NAO, Invitrogen) was used to determine the cardiolipin
content in the inner mitochondrial membrane as an indicator of mitochondrial
integrity. C2C12 myoblasts were transfected with M-cadherin-targeted (M-) or
scrambled siRNA (siCON) with NAO (250nM) at 37 ˚C. Fluorescence was
visualized with a Nikon eclipse E800 fluorescence microscope and digital images
were captured using a SPOT RT camera (Diagnostic Instruments). The fluorescence
intensity was analyzed and quantified using the ImageJ software (NIH).
To measure changes in the mitochondrial membrane potential, mitochondria were
isolated from M-cadherin RNAi or control cells and incubated with MitoTracker
Deep Red 633 (Molecular Probes, Carlsbad, CA), a mitochondria-specific marker
and analyzed by flow cytometry. This fluorescent dye diffuses passively into intact
and respiring mitochondria. The mitochondrial membrane potential (Dymt) was
estimated by staining the mitochondria with 5,59,6,69-tetrachloro-1,19,3,
39-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) (Molecular Probes). The
staining results of JC-1 orange/green were analyzed using a FACSCalibur system
(BD Bioscience) using Cell Quest Pro. 4.0 Software. 100,000 gated events were
collected for each sample.
Statistical analyses

The results are presented as mean ¡ s.e.m. Statistical analyses were performed
using the SPSS 13.0 software package. A one-way analysis of variance (ANOVA)
was used to compare differences in all measured variables. P,0.05 was considered
statistical significant.
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